Literature DB >> 27957102

Management Of Atrial Fibrillation In Patients With Heart Failure.

Andrew E Darby Md1.   

Abstract

Atrial fibrillation (AF) and heart failure (HF) are common conditions that frequently coexist. Both conditions share risk factors, are associated with increased morbidity and mortality, and may worsen the other. The presence of heart failure and symptoms associated with it may influence both the approach to management (i.e., rate versus rhythm control) and the treatment options available for AF patients. The presence of HF increases the stroke risk with atrial fibrillation, and thromboembolic risk reduction is paramount. Some patients with HF tolerate AF poorly and therefore , a rhythm control strategy may be preferred. More insight into the success rates with catheter ablation in heart failure has been gleaned from recent studies.

Entities:  

Year:  2014        PMID: 27957102      PMCID: PMC5135259          DOI: 10.4022/jafib.1105

Source DB:  PubMed          Journal:  J Atr Fibrillation        ISSN: 1941-6911


  78 in total

1.  A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation.

Authors:  Isabelle C Van Gelder; Vincent E Hagens; Hans A Bosker; J Herre Kingma; Otto Kamp; Tsjerk Kingma; Salah A Said; Julius I Darmanata; Alphons J M Timmermans; Jan G P Tijssen; Harry J G M Crijns
Journal:  N Engl J Med       Date:  2002-12-05       Impact factor: 91.245

Review 2.  2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society.

Authors:  Craig T January; L Samuel Wann; Joseph S Alpert; Hugh Calkins; Joaquin E Cigarroa; Joseph C Cleveland; Jamie B Conti; Patrick T Ellinor; Michael D Ezekowitz; Michael E Field; Katherine T Murray; Ralph L Sacco; William G Stevenson; Patrick J Tchou; Cynthia M Tracy; Clyde W Yancy
Journal:  J Am Coll Cardiol       Date:  2014-03-28       Impact factor: 24.094

Review 3.  Atrial fibrillation and congestive heart failure: specific considerations at the intersection of two common and important cardiac disease sets.

Authors:  Joachim R Ehrlich; Stanley Nattel; Stefan H Hohnloser
Journal:  J Cardiovasc Electrophysiol       Date:  2002-04

4.  Pulmonary vein vestibule ablation for the control of atrial fibrillation in patients with impaired left ventricular function.

Authors:  Claudio Tondo; Massimo Mantica; Giovanni Russo; Andrea Avella; Lucia De Luca; Augusto Pappalardo; Rafael Lopes Fagundes; Edo Picchio; Francesco Laurenzi; Vito Piazza; Irma Bisceglia
Journal:  Pacing Clin Electrophysiol       Date:  2006-09       Impact factor: 1.976

5.  Safety of percutaneous left atrial appendage closure: results from the Watchman Left Atrial Appendage System for Embolic Protection in Patients with AF (PROTECT AF) clinical trial and the Continued Access Registry.

Authors:  Vivek Y Reddy; David Holmes; Shephal K Doshi; Petr Neuzil; Saibal Kar
Journal:  Circulation       Date:  2011-01-17       Impact factor: 29.690

6.  Bisoprolol for the treatment of chronic heart failure: a meta-analysis on individual data of two placebo-controlled studies--CIBIS and CIBIS II. Cardiac Insufficiency Bisoprolol Study.

Authors:  Alain Leizorovicz; Philippe Lechat; Michel Cucherat; Françoise Bugnard
Journal:  Am Heart J       Date:  2002-02       Impact factor: 4.749

7.  Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: the Framingham Heart Study.

Authors:  Thomas J Wang; Martin G Larson; Daniel Levy; Ramachandran S Vasan; Eric P Leip; Philip A Wolf; Ralph B D'Agostino; Joanne M Murabito; William B Kannel; Emelia J Benjamin
Journal:  Circulation       Date:  2003-05-27       Impact factor: 29.690

8.  Long-term follow-up after atrial fibrillation ablation in patients with impaired left ventricular systolic function: the importance of rhythm and rate control.

Authors:  Sotirios Nedios; Philipp Sommer; Nikolaos Dagres; Jedrzej Kosiuk; Arash Arya; Sergio Richter; Thomas Gaspar; Nikolaos Kanagkinis; Borislav Dinov; Christopher Piorkowski; Andreas Bollmann; Gerhard Hindricks; Sascha Rolf
Journal:  Heart Rhythm       Date:  2013-12-27       Impact factor: 6.343

9.  Left ventricular systolic dysfunction by itself does not influence outcome of atrial fibrillation ablation.

Authors:  Tom De Potter; Antonio Berruezo; Lluis Mont; Maria Matiello; David Tamborero; Claudio Santibañez; Begoña Benito; Nibaldo Zamorano; Josep Brugada
Journal:  Europace       Date:  2010-01       Impact factor: 5.214

10.  Atrial fibrillation and outcomes in heart failure with preserved versus reduced left ventricular ejection fraction.

Authors:  David D McManus; Grace Hsu; Sue Hee Sung; Jane S Saczynski; David H Smith; David J Magid; Jerry H Gurwitz; Robert J Goldberg; Alan S Go
Journal:  J Am Heart Assoc       Date:  2013-02-01       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.